pazopanib

You have access
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World
VITTORIO GEBBIA, ANDREA GIRLANDO, ALFIO DI GRAZIA, IVAN FAZIO, NICOLÒ BORSELLINO, DARIO PIAZZA, VINCENZO SERRETTA, STEFANO PERGOLIZZI, ANTONIO PONTORIERO, ALBERTO FIRENZE and MARIA ROSARIA VALERIO

Anticancer Research December 2020, 40 (12) 7037-7043; DOI: https://doi.org/10.21873/anticanres.14730
You have access
Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case Report
LUCAS ZARLING, HAMID EMAMEKHOO, GAURI BHUTANI, TIMOTHY ZIEMLEWICZ, KRISTINA A. MATKOWSKYJ and CHRISTOS E. KYRIAKOPOULOS

Anticancer Research March 2020, 40 (3) 1527-1534; DOI: https://doi.org/10.21873/anticanres.14098
You have access
First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study
JOSEPH SGOUROS, GERASIMOS ARAVANTINOS, GEORGIA-ANGELIKI KOLIOU, GEORGE PENTHEROUDAKIS, FLORA ZAGOURI, AMANDA PSYRRI, DIMITRA IOANNA LAMPROPOULOU, STAMATINA DEMIRI, DIMITRIOS PECTASIDES, EVANGELIA RAZIS, GEORGE FOUNTZILAS and EPAMINONTAS SAMANTAS

Anticancer Research February 2020, 40 (2) 929-938; DOI: https://doi.org/10.21873/anticanres.14026
You have access
Eribulin Suppressed Cisplatinum- and Doxorubicin-resistant Recurrent Lung Metastatic Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model
TASUKU KIYUNA, YASUNORI TOME, KENTARO MIYAKE, TAKASHI MURAKAMI, HIROMICHI OSHIRO, KENTARO IGARASHI, KEI KAWAGUCHI, JOHN HSU, MANISH SINGH, YUNFENG LI, SCOTT NELSON, MICHAEL BOUVET, SHREE RAM SINGH, FUMINORI KANAYA and ROBERT M. HOFFMAN

Anticancer Research September 2019, 39 (9) 4775-4779; DOI: https://doi.org/10.21873/anticanres.13661
You have access
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas
MYRELLA VLENTERIE, WIM JG OYEN, NEELTJE STEEGHS, INGRID M.E. DESAR, REMY B. VERHEIJEN, ANNE MIEK KOENEN, WILLEM GROOTJANS, LIOE-FEE DE GEUS-OEI, NIELKA P. VAN ERP and WINETTE TA VAN DER GRAAF

Anticancer Research March 2019, 39 (3) 1309-1316; DOI: https://doi.org/10.21873/anticanres.13243
You have access
Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib
MAKI TODO, SUGURU SHIROTAKE, KOSHIRO NISHIMOTO, YOTA YASUMIZU, GOU KANEKO, HIDEYUKI KONDO, TAKASHI OKABE, HIDEKI MAKABE and MASAFUMI OYAMA

Anticancer Research February 2019, 39 (2) 999-1004; DOI: https://doi.org/10.21873/anticanres.13205
You have access
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma
MATTEO SANTONI, FRANCESCO PIVA, UGO DE GIORGI, ALESSANDRA MOSCA, UMBERTO BASSO, DANIELE SANTINI, SEBASTIANO BUTI, CRISTIAN LOLLI, CARLO TERRONE, MARCO MARUZZO, MICHELE IULIANI, MELISSA BERSANELLI, ALESSANDRO CONTI, ROBERTA MAZZUCCHELLI, RODOLFO MONTIRONI, LUCIANO BURATTINI and ROSSANA BERARDI

Anticancer Research October 2018, 38 (10) 5773-5782; DOI: https://doi.org/10.21873/anticanres.12916
You have access
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience
ANDREA SBRANA, ELISA BIASCO, FEDERICO PAOLIERI, ERICA PALESANDRO, CLAUDIA CASERTA, ROBERTO IACOVELLI, BEATRICE DETTI, DANIELE SANTINI, ALESSANDRA MOSCA, FRANCO MORELLI, GIUSEPPE FORNARINI, UGO DE GIORGI, CRISTINA MASINI and LUCA GALLI

Anticancer Research August 2018, 38 (8) 4913-4918; DOI: https://doi.org/10.21873/anticanres.12807
You have access
Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients
ALEXANDR POPRACH, ONDREJ FIALA, RENATA CHLOUPKOVA, BOHUSLAV MELICHAR, RADEK LAKOMY, KATARINA PETRAKOVA, MILADA ZEMANOVA, KATERINA KOPECKOVA, ONDREJ SLABY, HANA STUDENTOVA, JINDRICH KOPECKÝ, IGOR KISS, JINDRICH FINEK, LADISLAV DUSEK and TOMAS BUCHLER

Anticancer Research January 2018, 38 (1) 449-456;
You have access
Balancing Prolonged Survival with QoL Using Low-dose Pazopanib Maintenance: A Comparison with the PALETTE Study
KENSAKU ABE, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SHINJI MIWA, HIROYUKI INATANI, TAKASHI HIGUCHI, YUTA TANIGUCHI and HIROYUKI TSUCHIYA

Anticancer Research June 2016, 36 (6) 2893-2897;

Main menu

User menu

Search

pazopanib

Pages